Long intergenic non-protein coding RNA 2328 (LINC02328)

Long intergenic non-protein coding RNA 2328 (LINC02328) is a member of the long intergenic non-coding RNA (lincRNA) class, defined as transcripts longer than 200 nucleotides that do not overlap protein-coding genes and with little or no protein-coding capacity[1][7][9]. LincRNAs are increasingly recognized for diverse regulatory roles, including chromatin remodeling, transcriptional control, and serving as molecular scaffolds or decoys. While specific biological functions or disease associations of LINC02328 have not been described in the literature as of this writing, some lincRNAs can participate in gene expression regulation and are being investigated as disease biomarkers and potential therapeutic targets. LINC02328 currently lacks functional characterization and is not considered a validated therapeutic target[1][2][4][9]. Key points: - LINC02328 is not a protein, receptor, enzyme, or transporter, but an lincRNA gene/transcript[1][9]. - While lincRNAs are a focus of research for gene regulation and disease involvement, LINC02328 itself has not been validated as a therapeutic target, drug target, or clinical biomarker to date[1][2][4][9]. - Aliases include CTD-2341M24.1[9]. - No approved or experimental drugs are reported to interact with LINC02328. If you need further disease-specific or experimental information, more targeted experimental studies or non-coding RNA databases may be required, as LINC02328 is poorly characterized in current literature.

Other names

CTD-2341M24.1LINC02328

None known for drugs (not a known drug target)